Annual Cash & Cash Equivalents
$563.86 M
+$76.79 M+15.77%
December 31, 2023
Summary
- As of February 8, 2025, IMCR annual cash & cash equivalents is $563.86 million, with the most recent change of +$76.79 million (+15.77%) on December 31, 2023.
- During the last 3 years, IMCR annual cash & cash equivalents has risen by +$387.08 million (+218.96%).
- IMCR annual cash & cash equivalents is now at all-time high.
Performance
IMCR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$537.77 M
+$32.78 M+6.49%
September 30, 2024
Summary
- As of February 8, 2025, IMCR quarterly cash and cash equivalents is $537.77 million, with the most recent change of +$32.78 million (+6.49%) on September 30, 2024.
- Over the past year, IMCR quarterly cash and cash equivalents has increased by +$95.14 million (+21.49%).
- IMCR quarterly cash and cash equivalents is now -35.43% below its all-time high of $832.82 million, reached on March 31, 2024.
Performance
IMCR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IMCR Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +15.8% | +21.5% |
3 y3 years | +219.0% | +56.1% |
5 y5 years | +257.3% | +56.1% |
IMCR Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +75.6% | -35.4% | +113.1% |
5 y | 5-year | at high | +481.4% | -35.4% | +637.5% |
alltime | all time | at high | +481.4% | -35.4% | +637.5% |
Immunocore Holdings Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $537.77 M(+6.5%) |
Jun 2024 | - | $504.99 M(-39.4%) |
Mar 2024 | - | $832.82 M(+88.2%) |
Dec 2023 | $563.86 M(+15.8%) | $442.63 M(-0.3%) |
Sep 2023 | - | $444.06 M(+2.8%) |
Jun 2023 | - | $431.80 M(+3.3%) |
Mar 2023 | - | $417.95 M(+3.8%) |
Dec 2022 | $487.07 M | $402.47 M(+3.8%) |
Sep 2022 | - | $387.70 M(+53.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $252.36 M(-6.7%) |
Mar 2022 | - | $270.41 M(-15.8%) |
Dec 2021 | $321.06 M(+81.6%) | $321.06 M(-6.8%) |
Sep 2021 | - | $344.47 M(-10.7%) |
Jun 2021 | - | $385.96 M(-10.3%) |
Mar 2021 | - | $430.34 M(+143.4%) |
Dec 2020 | $176.78 M(+82.3%) | $176.78 M(+142.4%) |
Sep 2020 | - | $72.92 M(-24.8%) |
Dec 2019 | $96.98 M(-38.6%) | $96.98 M |
Dec 2018 | $157.83 M | - |
FAQ
- What is Immunocore Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Immunocore Holdings?
- What is Immunocore Holdings annual cash & cash equivalents year-on-year change?
- What is Immunocore Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Immunocore Holdings?
- What is Immunocore Holdings quarterly cash and cash equivalents year-on-year change?
What is Immunocore Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of IMCR is $563.86 M
What is the all time high annual cash & cash equivalents for Immunocore Holdings?
Immunocore Holdings all-time high annual cash & cash equivalents is $563.86 M
What is Immunocore Holdings annual cash & cash equivalents year-on-year change?
Over the past year, IMCR annual cash & cash equivalents has changed by +$76.79 M (+15.77%)
What is Immunocore Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IMCR is $537.77 M
What is the all time high quarterly cash and cash equivalents for Immunocore Holdings?
Immunocore Holdings all-time high quarterly cash and cash equivalents is $832.82 M
What is Immunocore Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, IMCR quarterly cash and cash equivalents has changed by +$95.14 M (+21.49%)